KR102199666B1 - Mycelium Tremella fucifomis TFCUV5 mutant strain having high growth rate and polysaccharide productivity and uses thereof - Google Patents
Mycelium Tremella fucifomis TFCUV5 mutant strain having high growth rate and polysaccharide productivity and uses thereof Download PDFInfo
- Publication number
- KR102199666B1 KR102199666B1 KR1020180068699A KR20180068699A KR102199666B1 KR 102199666 B1 KR102199666 B1 KR 102199666B1 KR 1020180068699 A KR1020180068699 A KR 1020180068699A KR 20180068699 A KR20180068699 A KR 20180068699A KR 102199666 B1 KR102199666 B1 KR 102199666B1
- Authority
- KR
- South Korea
- Prior art keywords
- polysaccharide
- tfcuv5
- strain
- mycelium
- trimella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 121
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 121
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 121
- 230000012010 growth Effects 0.000 title claims abstract description 19
- 241001506047 Tremella Species 0.000 title description 10
- 238000004519 manufacturing process Methods 0.000 claims abstract description 32
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 32
- 239000008103 glucose Substances 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 16
- 229940041514 candida albicans extract Drugs 0.000 claims description 16
- 239000012138 yeast extract Substances 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 13
- 230000003020 moisturizing effect Effects 0.000 claims description 11
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims description 10
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 10
- 229940097043 glucuronic acid Drugs 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 8
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 6
- -1 blockers Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 4
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 4
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000004088 foaming agent Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000003349 gelling agent Substances 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000003352 sequestering agent Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000000375 suspending agent Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract description 42
- 238000000605 extraction Methods 0.000 abstract description 5
- 239000004909 Moisturizer Substances 0.000 abstract description 4
- 230000001333 moisturizer Effects 0.000 abstract description 4
- 238000000746 purification Methods 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000009467 reduction Effects 0.000 abstract description 4
- 229920000642 polymer Polymers 0.000 abstract description 3
- 239000002609 medium Substances 0.000 description 34
- 101100424913 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TFC6 gene Proteins 0.000 description 19
- 101100365572 Schizosaccharomyces pombe (strain 972 / ATCC 24843) sfc6 gene Proteins 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 239000001888 Peptone Substances 0.000 description 7
- 108010080698 Peptones Proteins 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 235000019319 peptone Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000012228 culture supernatant Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 108700022487 rRNA Genes Proteins 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241000908178 Tremella fuciformis Species 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000000569 multi-angle light scattering Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101500000959 Bacillus anthracis Protective antigen PA-20 Proteins 0.000 description 1
- 208000034628 Celiac artery compression syndrome Diseases 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000012366 Fed-batch cultivation Methods 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- NIKBMHGRNAPJFW-IUCAKERBSA-N His-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 NIKBMHGRNAPJFW-IUCAKERBSA-N 0.000 description 1
- 108091023242 Internal transcribed spacer Proteins 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- DZHDVYLBNKMLMB-ZFWWWQNUSA-N Trp-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 DZHDVYLBNKMLMB-ZFWWWQNUSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000013365 molecular weight analysis method Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 238000005373 pervaporation Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- C12R1/645—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 및 이의 용도에 관한 것으로, 본 발명의 생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 제공함으로써, 흰목이버섯 유래의 고분자 다당체가 사용감 및 열안정성, pH 안정성이 우수하지만 그동안 흰목이버섯 자실체에서 생산된 다당체를 이용한 보습제의 제조는 원재료인 다당체 수급의 불안정 및 추출정제 공정의 어려움이 있어 이용이 용이하지 못했던 문제점을 해결할 수 있다. 따라서, 본 발명을 통해 순수분리되고, 선발된 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 이용한 배양을 통하여 고보습 다당체를 생산하는 것은 제조 단가절감 및 균일품질의 제품제조가능성 등 보다 경제적일 것으로 판단되므로, 관련 산업에 매우 유용하다.The present invention relates to a mycelium trimella fusiformis TFCUV5 mutant strain having excellent growth rate and polysaccharide productivity, and to a use thereof, and by providing a mycelium trimella fusiformis TFCUV5 mutant strain having excellent growth rate and polysaccharide productivity of the present invention, The derived polymer polysaccharide has excellent feeling of use, thermal stability, and pH stability, but the production of a moisturizer using polysaccharides produced from the fruiting body of white-throated mushrooms has not been easy to use due to instability in supply and demand of the raw material polysaccharide and difficulties in the extraction and purification process. Can be solved. Therefore, it is judged to be more economical to produce high-moisturizing polysaccharides through cultivation using purely isolated and selected mycelium trimella fusformis TFCUV5 mutant strains through the present invention, such as cost reduction and the possibility of producing products of uniform quality. , Very useful for related industries.
Description
본 발명은 생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 및 이의 용도에 관한 것이다.The present invention relates to a mycelial trimella fusformis TFCUV5 mutant strain having excellent growth rate and polysaccharide productivity, and uses thereof.
천연 고분자다당체를 이용하는 보습화장품은 화장품의 필수적인 소재로 오랫동안 시장에서 인기 있는 제품으로 판대되고 있다. 대표적인 보습다당체로는 히아루론산, 치마버벗베타글루칸, 레반 등이 사용되어 왔으나 히아루론산의 경우 고가이며 열안정성이 낮고 발효제조공정의 어려움으로 그 사용이 제한적이다. 치마버섯 베타글루칸의 경우 제조공정의 잦은 오염 및 낮은 생산수율이 문제로 지적되고 있다. 레반의 경우는 끈적임으로 인한 사용감 저하와 낮은 열안정성으로 널리 사용하기에 문제를 가지고 있다.Moisturizing cosmetics using natural polymer polysaccharides are essential materials for cosmetics and have long been popular in the market. Representative moisturizing polysaccharides such as hyaluronic acid, cimaberbot beta-glucan, and leban have been used, but hyaluronic acid is expensive and has low thermal stability, and its use is limited due to difficulties in the fermentation manufacturing process. In the case of the beta-glucan of skirt mushrooms, frequent contamination of the manufacturing process and low production yield are pointed out as problems. In the case of Leban, there is a problem in being widely used due to the decrease in feeling of use due to stickiness and low thermal stability.
흰목이버섯 유래의 고분자다당체는 사용감 및 열안정성, pH 안정성이 우수하나 흰목이버섯 자실체를 이용한 다당보습제의 제조는 원재료 수급의 불안정 및 추출 정제공정의 어려움이 있으므로 균사체를 이용한 배양을 통하여 고보습다당체를 생산하는 것이 제조 단가절감 및 균일품질의 제품제조가능 등 보다 경제적일 것으로 판단된다. High molecular weight polysaccharides derived from white-necked mushrooms have excellent feeling of use, thermal stability, and pH stability, but production of polysaccharide moisturizers using white-necked mushrooms fruiting body has instability in the supply and demand of raw materials and difficulty in extraction and purification processes. Therefore, highly moisturizing polysaccharides through culture using mycelium It is considered to be more economical to produce the product, such as cost reduction and production of uniform quality products.
한편, 한국공개특허 제2008-0079962호에서는 '흰목이 버섯 균사체 유래의 항당뇨 활성 세포외다당체 및 그 제조방법'이 개시되어 있고, 한국공개특허 제2006-0020548호에서는 '혈당강하 효과를 나타내는 흰목이 버섯(Tremella fuciformis) 조다당체 추출물과 이를 포함하는 당뇨병예방 및 치료를 위한 조성물'이 개시되어 있으나, 본 발명에서와 같이, '생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 및 이의 용도'에 대해서는 개시된 바가 전혀 없다.On the other hand, Korean Patent Publication No. 2008-0079962 discloses'Antidiabetic active extracellular polysaccharide derived from white-necked mushroom mycelium and a method for preparing the same', and Korean Patent Publication No. 2006-0020548 discloses'white color showing hypoglycemic effect. Throat mushroom ( Tremella fuciformis ) Crude polysaccharide extract and a composition for preventing and treating diabetes containing the same, but as in the present invention, as in the present invention, for'mycelium trimella fusformis TFCUV5 mutant strain and its use excellent in growth rate and polysaccharide productivity' Nothing has been disclosed.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명에서는 흰목이버섯 자실체로부터 순수분리한 균사체 트리멜라 푸시포미스 TFC6 균주를 대상으로 UV 조사에 의한 돌연변이를 유발시켜 최종적으로 모균주보다 생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주(기탁번호: KCTC18504P)를 분리할 수 있었다.The present invention was derived from the above requirements, and in the present invention, in the present invention, the mycelium trimella fusformis TFC6 strain purely isolated from the fruiting body of White-throated mushrooms caused mutations by UV irradiation, and finally, the growth rate and It was possible to isolate the mycelium trimella fusformis TFCUV5 mutant strain (accession number: KCTC18504P) having excellent polysaccharide productivity.
본 발명의 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주는 대조구 균주와 동일 조건에서 배양한 후 다당체 생산성을 확인한 결과, MCM 배지에서 배양 6일째 최대 3.6g/l, 25℃에서 최대 2.6g/l, pH 7.0에서 최대 2.7g/l, 교반속도 300rpm에서 최대 3.2g/l, 공기주입량 2.0vvm에서 최대 4.3g/l인 점을 확인하였고, 이를 바탕으로 MCM 배지에서, 25℃, pH 7.0, 300rpm, 2.0vvm인 조건으로 유가식 배양을 수행한 결과, 108시간째에 약 39.6g/L의 글루코즈를 사용하여 8.4g/L의 다당체를 생산하였고, 다당체 생산성은 1.9g/L·day임을 확인할 수 있었는데, 이는 사용된 글루코스 영양원 대비 다당체 생산수율이 0.19g/g인 것으로, 이미 보고된 다른 흰목이버섯 유래 균사체들의 다당체 생산 결과들과 비교해 볼 때, TFCUV5 변이균주는 매우 우수한 다당체 생산성을 나타내는 것을 확인한 것이다.The mycelial trimella fusformis TFCUV5 mutant strain of the present invention was cultivated under the same conditions as the control strain, and the polysaccharide productivity was confirmed. As a result, the maximum of 3.6 g/l at the 6th day of culture in MCM medium, the maximum of 2.6 g/l at 25° C., pH It was confirmed that the maximum 2.7g/l at 7.0, the maximum 3.2g/l at the stirring speed 300rpm, and the maximum 4.3g/l at 2.0vvm air injection volume were confirmed, and based on this, in MCM medium, 25℃, pH 7.0, 300rpm, 2.0 As a result of performing fed-batch culture under the condition of vvm, 8.4 g/L of polysaccharide was produced using about 39.6 g/L of glucose at 108 hours, and the polysaccharide productivity was confirmed to be 1.9 g/L·day. It was confirmed that the polysaccharide production yield was 0.19 g/g compared to the glucose nutrient used, and compared with the previously reported polysaccharide production results of other white mushroom-derived mycelium, the TFCUV5 mutant strain showed very good polysaccharide productivity.
그동안, 흰목이버섯 유래의 고분자 다당체는 사용감 및 열안정성, pH 안정성이 우수하나 흰목이버섯 자실체에서 생산된 다당체를 이용한 보습제의 제조는 원재료인 다당체 수급의 불안정 및 추출정제 공정의 어려움이 있었으나, 본 발명을 통해 순수분리되고, 선발된 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 이용한 배양을 통하여 고보습 다당체를 생산하는 것은 제조 단가절감 및 균일품질의 제품제조 가능성 등 보다 경제적인 점을 확인함으로써, 본 발명을 완성하였다.In the meantime, polymer polysaccharides derived from white-throated mushrooms have excellent feeling of use, thermal stability, and pH stability, but the manufacture of moisturizers using polysaccharides produced from white-throated mushrooms has suffered instability in the supply and demand of polysaccharides as a raw material and difficulties in the extraction and purification process. The production of highly moisturizing polysaccharides through culture using the purely isolated and selected mycelium trimela fusformis TFCUV5 mutant strain through the invention confirmed more economical points such as reduction in manufacturing cost and the possibility of manufacturing products of uniform quality. The invention was completed.
상기 과제를 해결하기 위해, 본 발명은 생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스(Tremella fucifomis) TFCUV5 돌연변이 균주(기탁번호: KCTC18504P)를 제공한다.In order to solve the above problems, the present invention is a mycelium trimella fusiformis excellent in growth rate and polysaccharide productivity ( Tremella fucifomis ) TFCUV5 mutant strain (accession number: KCTC18504P) is provided.
또한, 본 발명은 상기 균주 또는 이의 배양액을 유효성분으로 함유하는 다당체 생산용 조성물을 제공한다.In addition, the present invention provides a composition for producing a polysaccharide containing the strain or a culture medium thereof as an active ingredient.
또한, 본 발명은 상기 균주 또는 이의 배양액을 유효성분으로 포함하는 피부 보습용 화장료 조성물을 제공한다.In addition, the present invention provides a skin moisturizing cosmetic composition comprising the strain or a culture solution thereof as an active ingredient.
또한, 본 발명은 상기 균주를 배양하는 단계를 포함하는 다당체를 생산하는 방법을 제공한다.In addition, the present invention provides a method for producing a polysaccharide comprising the step of culturing the strain.
본 발명의 생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 제공함으로써, 흰목이버섯 유래의 고분자 다당체가 사용감 및 열안정성, pH 안정성이 우수하지만 그동안 흰목이버섯 자실체에서 생산된 다당체를 이용한 보습제의 제조는 원재료인 다당체 수급의 불안정 및 추출정제 공정의 어려움이 있어 이용이 용이하지 못했던 문제점을 해결할 수 있다. By providing the mycelium trimella fusformis TFCUV5 mutant strain having excellent growth rate and polysaccharide productivity of the present invention, the high molecular polysaccharide derived from white-throated mushroom has excellent feeling of use, heat stability, and pH stability, but the polysaccharide produced from the fruiting body of white-necked mushroom The preparation of the used moisturizer can solve the problem that it was not easy to use due to instability in supply and demand of polysaccharides as a raw material and difficulties in the extraction and purification process.
따라서, 본 발명을 통해 순수분리되고, 선발된 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 이용한 배양을 통하여 고보습 다당체를 생산하는 것은 제조 단가절감 및 균일품질의 제품제조가능성 등 보다 경제적일 것으로 판단되므로, 관련 산업에 매우 유용하다.Therefore, it is judged to be more economical to produce high-moisturizing polysaccharides through cultivation using purely isolated and selected mycelium trimella fusformis TFCUV5 mutant strains through the present invention, such as cost reduction and the possibility of producing products of uniform quality. , Very useful for related industries.
도 1은 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFC6 균주의 균사(상) 및 콜로니(하)를 나타낸 것이다.
도 2는 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFC6 균주의 분류학적 계통도를 나타낸 것이다.
도 3은 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFC6 균주를 MCM 배지에서 배양한 후 생장곡선(검은 선), 배지 내 잔존 당량(회색 선) 및 생성 다당체량(블루바)을 나타낸 것이다.
도 4는 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFC6 균주를 PDA 배지에서 배양한 후 생장곡선(검은 선), 배지 내 잔존 당량(회색 선) 및 생성 다당체량(블루 바)을 나타낸 것이다.
도 5는 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFC6 균주에 UV를 조사한 후 생존율을 시간에 따라 조사한 결과를 나타낸 것이다.
도 6은 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주의 생장곡선(검은 선) 및 생성 다당체량(블루바)을 나타낸 것이다.
도 7은 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주의 배양 온도에 따른 생성 다당체량(블루바)을 EPS(g/l)로 나타낸 것이다.
도 8은 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주의 배양시 초기 pH에 따른 생성 다당체량(블루바)을 EPS(g/l)로 나타낸 것이다.
도 9는 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주의 배양시 교반 속도에 따른 생성 다당체량을 EPS(g/l)로 나타낸 것이다.
도 10은 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주의 배양시 공기 주입량에 따른 생성 다당체량을 EPS(g/l)로 나타낸 것이다.
도 11은 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 유가식 배양을 수행한 후 배양 상등액의 글루코즈 소비량과 다당체 생성량을 조사한 결과이다.
도 12는 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 유래의 다당체 아미노산을 분석한 결과이다.
도 13은 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 유래의 다당체 구조를 분석한 결과이다.
도 14는 본 발명에서 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 유래의 다당체의 분자량을 분석한 결과이다.Figure 1 shows the hyphae (top) and colonies (bottom) of the white-necked mushroom mycelium trimella fusiformis TFC6 strain isolated in the present invention.
Figure 2 shows the taxonomic system diagram of the white-throated mushroom mycelium trimella fusiformis TFC6 strain isolated in the present invention.
Figure 3 shows the growth curve (black line), residual equivalent in the medium (gray line) and the amount of polysaccharide produced (blue bar) after culturing the white tree ear mushroom mycelium trimela fusformis TFC6 strain isolated in the present invention in MCM medium. Is shown.
Figure 4 shows the growth curve (black line), residual equivalent in the medium (gray line), and the amount of polysaccharide produced (blue bar) after culturing the white tree ear mushroom mycelium trimella fusformis TFC6 strain isolated in the present invention in PDA medium. Is shown.
Figure 5 shows the result of irradiating the survival rate over time after UV irradiation on the white-necked mushroom mycelium trimella fusformis TFC6 strain isolated in the present invention.
Figure 6 shows the growth curve (black line) and the amount of polysaccharide produced (blue bar) of the white tree mushroom mycelium trimella fusiformis TFCUV5 mutant strain isolated in the present invention.
Figure 7 shows the amount of polysaccharide produced (blue bar) according to the culture temperature of the white-necked mushroom mycelium trimella fusiformis TFCUV5 mutant strain isolated in the present invention in EPS (g/l).
Figure 8 shows the amount of polysaccharide produced (blue bar) according to the initial pH during cultivation of the white tree mushroom mycelium trimella fusiformis TFCUV5 mutant strain isolated in the present invention in EPS (g/l).
Figure 9 shows the amount of polysaccharide produced according to the stirring speed when cultivating the white tree mushroom mycelium trimella fusiformis TFCUV5 mutant strain isolated in the present invention in EPS (g / l).
FIG. 10 shows the amount of polysaccharide produced according to the amount of air injected in the cultivation of the white-necked mushroom mycelium trimella fusiformis TFCUV5 mutant strain isolated in the present invention in EPS (g/l).
FIG. 11 is a result of examining the glucose consumption and polysaccharide production amount of the culture supernatant after fed-batch culture of the white-necked mushroom mycelium trimela fusformis TFCUV5 mutant strain isolated in the present invention.
Figure 12 is a white-throated mushroom mycelium trimella fusiformis TFCUV5 mutant strain isolated in the present invention This is the result of analyzing the derived polysaccharide amino acid.
Figure 13 is a white-throated mushroom mycelium trimella fusiformis TFCUV5 mutant strain isolated in the present invention This is the result of analyzing the derived polysaccharide structure.
Figure 14 is a white-throated mushroom mycelium trimella fusiformis TFCUV5 mutant strain isolated in the present invention It is the result of analyzing the molecular weight of the derived polysaccharide.
본 발명의 목적을 달성하기 위하여, 본 발명은 생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스(Tremella fucifomis) TFCUV5 돌연변이 균주(기탁번호: KCTC18504P)를 제공한다.In order to achieve the object of the present invention, the present invention has excellent growth rate and polysaccharide productivity, mycelium trimella fusiformis ( Tremella fucifomis ) TFCUV5 mutant strain (accession number: KCTC18504P) is provided.
본 발명에서는 흰목이버섯 자실체로부터 순수분리한 균사체 트리멜라 푸시포미스 TFC6 균주를 대상으로 UV 조사에 의한 돌연변이를 유발시켜 최종적으로 모균주보다 생장율 및 다당체 생산성이 우수한 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주(기탁번호: KCTC18504P)를 분리할 수 있었다.In the present invention, the mycelium trimella fusformis TFCUV5 mutant strain, which has excellent growth rate and polysaccharide productivity than the parent strain, is finally induced by inducing mutations by UV irradiation targeting the mycelium trimella fusformis TFC6 strain purely isolated from the fruiting body of White-throated mushrooms. (Accession No.: KCTC18504P) could be separated.
본 발명의 균사체 트리멜라 푸시포미스 TFCUV5 돌연변이 균주는 대조구 균주와 동일 조건에서 배양한 후 다당체 생산성을 확인한 결과, MCM 배지에서 배양 6일째 최대 3.6g/l, 25℃에서 최대 2.6g/l, pH 7.0에서 최대 2.7g/l, 교반속도 300rpm에서 최대 3.2g/l, 공기주입량 2.0vvm에서 최대 4.3g/l인 점을 확인하였고, 이를 바탕으로 MCM 배지에서, 25℃, pH 7.0, 300rpm, 2.0vvm인 조건으로 유가식 배양을 수행한 결과, 108시간째에 약 39.6g/L의 글루코즈를 사용하여 8.4g/L의 다당체를 생산하였고, 다당체 생산성은 1.9g/L·day임을 확인하였으며(도 11), 따라서, 상기 균주를 한국생명공학연구원(KCTC)에 기탁번호가 KCTC18504P로 2016년 10월 31일에 기탁하였다.The mycelial trimella fusformis TFCUV5 mutant strain of the present invention was cultivated under the same conditions as the control strain, and the polysaccharide productivity was confirmed. As a result, the maximum of 3.6 g/l at the 6th day of culture in MCM medium, the maximum of 2.6 g/l at 25° C., pH It was confirmed that the maximum 2.7g/l at 7.0, the maximum 3.2g/l at the stirring speed 300rpm, and the maximum 4.3g/l at 2.0vvm air injection volume were confirmed, and based on this, in MCM medium, 25℃, pH 7.0, 300rpm, 2.0 As a result of performing fed-batch culture under the condition of vvm, it was confirmed that 8.4 g/L of polysaccharide was produced using about 39.6 g/L of glucose at 108 hours, and the polysaccharide productivity was 1.9 g/L·day (Fig. 11) Therefore, the strain was deposited with the Korea Research Institute of Bioscience and Biotechnology (KCTC) under the accession number KCTC18504P on October 31, 2016.
본 발명의 일 구현 예에 따른 방법에서, 상기 다당체는 만노스, 자일로스, 글루쿠론산, 푸코스 및 글루코스로 이루어질 수 있고, 바람직하게는 만노스, 자일로스, 글루쿠론산, 푸코스 및 글루코스가 각각 40.3, 22.0, 19.3, 17.1, 1.3%의 구성을 나타내는 다당체일 수 있으나, 이에 제한되지 않는다.In the method according to an embodiment of the present invention, the polysaccharide may be composed of mannose, xylose, glucuronic acid, fucose and glucose, and preferably mannose, xylose, glucuronic acid, fucose and glucose are each It may be a polysaccharide having a composition of 40.3, 22.0, 19.3, 17.1, 1.3%, but is not limited thereto.
또한, 본 발명은 상기 균주 또는 이의 배양액을 유효성분으로 함유하는 다당체 생산용 조성물을 제공한다.In addition, the present invention provides a composition for producing a polysaccharide containing the strain or a culture medium thereof as an active ingredient.
본 발명의 일 구현 예에 따른 조성물에서, 상기 균주는 트리멜라 푸시포미스(Tremella fucifomis) 균주일 수 있고, 바람직하게는 균사체 트리멜라 푸시포미스(Tremella fucifomis) TFCUV5 돌연변이 균주(기탁번호: KCTC18504P)일 수 있으나, 이에 제한되지 않는다.In the composition according to an embodiment of the present invention, the strain is trimella fusiformis ( Tremella fucifomis ) may be a strain, preferably mycelium trimella fuciformis ( Tremella fucifomis ) TFCUV5 mutant strain (accession number: KCTC18504P) may be, but is not limited thereto.
또한, 본 발명은 상기 균주 또는 이의 배양액을 유효성분으로 포함하는 피부 보습용 화장료 조성물을 제공한다.In addition, the present invention provides a skin moisturizing cosmetic composition comprising the strain or a culture solution thereof as an active ingredient.
본 발명의 상기 균주 또는 이의 배양액은 동결건조한 분말 형태인 것이 바람직하지만, 이에 한정하지 않는다.The strain or a culture solution thereof of the present invention is preferably a lyophilized powder form, but is not limited thereto.
본 발명의 화장료 조성물은 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로 에멀젼, 마이크로캡슐, 미세과립구 또는 이온형 리포좀, 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 에센스, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition of the present invention is a solution, gel, anhydrous product of a solid or paste, an emulsion obtained by dispersing an oil phase in an aqueous phase, a suspension, a microemulsion, a microcapsule, a microgranular sphere or an ionic liposome, a nonionic vesicle dispersant in the form, a cream , Skin, lotion, powder, ointment, essence, spray, or can be provided in the form of a conceal stick. In addition, it may be prepared in the form of a foam or an aerosol composition further containing a compressed propellant.
또한, 상기 화장료 조성물은 본 발명의 균주 또는 이의 배양액에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화 제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition is a fatty substance, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, an interface Actives, water, ionic or nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic actives, lipid vesicles or cosmetics It may contain adjuvants commonly used in the cosmetic field, such as any other ingredients commonly used.
본 발명의 일 구현 예에 따른 조성물에서, 상기 균주는 트리멜라 푸시포미스(Tremella fucifomis) 균주일 수 있고, 바람직하게는 균사체 트리멜라 푸시포미스(Tremella fucifomis) TFCUV5 돌연변이 균주(기탁번호: KCTC18504P)일 수 있으나, 이에 제한되지 않는다.In the composition according to an embodiment of the present invention, the strain is trimella fusiformis ( Tremella fucifomis ) may be a strain, preferably mycelium trimella fuciformis ( Tremella fucifomis ) TFCUV5 mutant strain (accession number: KCTC18504P) may be, but is not limited thereto.
본 발명의 피부 보습용 화장료 조성물은 상기 균주 또는 이의 배양액 이외에 공지의 피부 보습용 성분을 추가로 포함할 수 있다. 추가적인 피부건강에 도움을 주는 원료를 포함하게 되면, 본 발명의 피부 보습용 화장료 조성물의 효과는 더욱 증진될 수 있을 것이며, 피부건강에 도움을 주는 원료의 추가 시에는 복합사용에 따른 피부 안전성, 제형화의 용이성, 유효성분들의 안정성을 고려할 수 있다.The cosmetic composition for moisturizing skin of the present invention may further include a known skin moisturizing component in addition to the strain or a culture solution thereof. If additional ingredients that help skin health are included, the effect of the cosmetic composition for moisturizing skin of the present invention can be further enhanced, and when ingredients that help skin health are added, skin safety and formulation according to combination use Ease of fire and stability of active ingredients can be considered.
또한, 본 발명은 상기 균주를 배양하는 단계를 포함하는 다당체를 생산하는 방법을 제공한다.In addition, the present invention provides a method for producing a polysaccharide comprising the step of culturing the strain.
본 발명의 상기 다당체를 생산하는 방법은 균주의 배양액으로부터의 다당체를 회수하는 단계를 추가로 포함할 수 있다. 상기 균주의 배양액으로부터의 다당체를 회수하는 단계는 통상적인 분리 기술, 예를 들어 증류, 전기투석, 투과증발, 크로마토그라피, 용매추출, 반응추출 등을 이용할 수 있으며, 통상적으로 순도가 높은 물질을 분리하기 위하여 이들을 조합하여 이용할 수 있다.The method of producing the polysaccharide of the present invention may further include the step of recovering the polysaccharide from the culture medium of the strain. The step of recovering the polysaccharide from the culture medium of the strain may use conventional separation techniques, such as distillation, electrodialysis, pervaporation, chromatography, solvent extraction, reaction extraction, and the like, and usually separate substances of high purity. In order to do this, they can be used in combination.
본 발명의 균주를 배양하는 방법은 당업계에 통상적으로 이용되는 방법에 따라 배양할 수 있으며, 특별한 방법에 한정되는 것은 아니다.The method of culturing the strain of the present invention may be cultured according to a method commonly used in the art, and is not limited to a specific method.
본 발명의 일 구현 예에 따른 방법에서, 상기 배양은 탄소원으로 글루코스를 첨가하고, 질소원으로 효모 추출물을 첨가하여 제조된 MCM 배지에서, 24~26℃, pH 6.5~9.5, 270~330rpm, 1.8~2.2vvm인 조건으로 유가식 배양을 수행하는 것일 수 있고, 바람직하게는 탄소원으로 글루코스를 첨가하고, 질소원으로 효모 추출물을 첨가하여 제조된 MCM 배지에서, 25℃, pH 7, 300rpm, 2vvm인 조건으로 유가식 배양을 수행하는 것일 수 있으나, 이에 제한되지 않는다.In the method according to an embodiment of the present invention, the culture is in MCM medium prepared by adding glucose as a carbon source and yeast extract as a nitrogen source, 24 to 26°C, pH 6.5 to 9.5, 270 to 330 rpm, 1.8 to In the MCM medium prepared by adding glucose as a carbon source and yeast extract as a nitrogen source, preferably performing fed-batch culture under conditions of 2.2 vvm, under conditions of 25°C,
본 발명의 일 구현 예에 따른 방법에서, 상기 MCM(Mushroom complete medium) 배지는 균주 배양을 위해 당업계에 일반적으로 사용되는 MCM 배지로, 글루코스 20g/L, 효모 추출물 2g/L가 첨가되고, 펩톤 2g/L, MgSO4·7H2O 0.5g/L, K2HPO4 1g/L, KH2PO4 0.46g/L가 첨가되어 제조된 배지일 수 있으나, 이에 제한되지 않는다.In the method according to an embodiment of the present invention, the MCM (Mushroom complete medium) medium is an MCM medium generally used in the art for culturing strains, glucose 20g/L, yeast extract 2g/L are added, and peptone 2g/L, MgSO 4 ·7H 2 O 0.5g/L, K 2 HPO 4 1g/L, KH 2 PO 4 0.46 g/L may be added to prepare a medium, but is not limited thereto.
본 발명의 일 구현 예에 따른 방법에서, 상기 글루코스는 18~22g/l, 효모 추출물은 1.8~2.2g/l로 첨가하는 것일 수 있고, 바람직하게는 글루코스는 20g/l, 효모 추출물은 2g/l로 첨가하는 것일 수 있으나, 이에 제한되지 않는다.In the method according to an embodiment of the present invention, the glucose may be added at 18 to 22 g/l, the yeast extract at 1.8 to 2.2 g/l, preferably glucose is 20 g/l, and the yeast extract is 2 g/l. It may be added as l, but is not limited thereto.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are only illustrative of the present invention, and the contents of the present invention are not limited to the following examples.
실시예Example 1. 본 발명에서 1. In the present invention 흰목이버섯White-throated mushroom 균사체 mycelium 트리멜라Trimella 푸시포미스Push Formis TFC6TFC6 균주의 분리 Isolation of strains
흰목이버섯 균사체 분리를 위하여 흰목이버섯 자실체를 감자한천배지(PDA, pH 5.5) 위에서 두드려 포자가 떨어지도록 유도하였고, 이를 25℃, 인큐베이터에서 배양하였다. 도 1에서와 같이, 배양 후 7일째에 점성을 띄며 자라는 콜로니를 확보하여 현미경으로 관찰하였을 때 효모와 같은 세포 형태를 확인하였으며(도 1), 이를 순수분리하였다. In order to isolate the white-necked mushroom mycelium, the white-necked mushroom fruiting bodies were tapped on potato agar medium (PDA, pH 5.5) to induce spores to fall, and this was cultured in an incubator at 25°C. As shown in FIG. 1, when a colony that grows viscous on the 7th day after culture was secured and observed under a microscope, a yeast-like cell morphology was confirmed (FIG. 1), and this was purely isolated.
신규 분리한 흰목이버섯 균사체 트리멜라 푸시포미스 TFC6 균주의 분자생물학적 동정을 위하여 18S rRNA 유전자 서열을 분석하였다. 하나의 콜로니로부터 게놈 DNA 추출 키트(Invitrogen, Germany)를 이용하여 염색체 DNA를 분리한 후, 이 게놈 DNA를 주형으로 AccuPower®Pfu PCR PreMix를 이용하여 ITS 영역과 large subunit rRNA 유전자의 염기서열을 PCR법으로 증폭하였다. PCR 수행에 사용된 프라이머는 아래 표 1에 나타내었다.The 18S rRNA gene sequence was analyzed for molecular biological identification of the newly isolated white-necked mushroom mycelium trimella fusformis TFC6 strain. After separating chromosomal DNA from a single colony using a genomic DNA extraction kit (Invitrogen, Germany), the nucleotide sequence of the ITS region and large subunit rRNA gene was PCR method using the genomic DNA as a template using AccuPower® Pfu PCR PreMix. Was amplified. Primers used to perform PCR are shown in Table 1 below.
rRNA geneLarge subunit
rRNA gene
PCR 산물은 솔젠트(주)에 의해 염기서열을 확인하였으며, ITS 영역과 Large subunit rRNA 유전자에 대한 유효한 염기서열로 각각 295bp(서열번호 1)와 570bp(서열번호 2)를 확보하였다. 이 염기서열은 NCBI blast와 EZbiocloud EzFungi를 통하여 상동성을 확인하였으며, 흰목이버섯 트리멜라 푸시포미스 CCJ1531과 99.8% 일치하였다. 염기서열 상동성 분석을 실시한 결과를 토대로 분리한 흰목이버섯 균사체를 트리멜라 푸시포미스 (Tremella fuciformis) TFC6 균주로 명명하였다(도 2). The nucleotide sequence of the PCR product was confirmed by Solgent Co., Ltd., and 295 bp (SEQ ID NO: 1) and 570 bp (SEQ ID NO: 2) were obtained as effective nucleotide sequences for the ITS region and the large subunit rRNA gene, respectively. This nucleotide sequence was confirmed by NCBI blast and EZbiocloud EzFungi. It was 99.8% consistent with CCJ1531. Based on the result of nucleotide sequence homology analysis, the isolated white-necked mushroom mycelium was treated with Trimella fusformis ( Tremella fuciformis ) was named TFC6 strain (Fig. 2).
실시예Example 2. 본 발명에서 분리한 2. Separated from the present invention 흰목이버섯White-throated mushroom 균사체 mycelium 트리멜라Trimella 푸시포미스Push Formis TFC6TFC6 균주의 다당체 생산 및 다당체 조성 분석 Polysaccharide production and polysaccharide composition analysis of strain
분리된 트리멜라 푸시포미스 TFC6 균주로부터 다당체 생산량을 확인하였다. 전배양은 PDA(감자전분 4g/L, 글루코스 20g/L) 배지에서 25℃, 200rpm, 3일간 배양한 후 원심분리를 통하여 세포를 회수하였고, 이를 다시 PDA와 MCM (Mushroom complete medium, 글루코스 20g/L, 효모 추출물 2g/L, 펩톤 2g/L, MgSO4·7H2O 0.5g/L, K2HPO4 1g/L, KH2PO4 0.46g/L) 배지에 초기 접종농도가 OD600에서 0.3이 되도록 접종하여, 25℃에서 200rpm으로 진탕 배양하였으며 24시간마다 샘플링하여 OD값과 배지 내 잔존 당량 및 생성 다당체량을 확인하였다(도 3 및 도 4).Polysaccharide production was confirmed from the isolated trimella fusformis TFC6 strain. The pre-culture was carried out in PDA (potato starch 4g/L, glucose 20g/L) medium at 25°C, 200 rpm for 3 days, and then the cells were recovered through centrifugation. This was again performed with PDA and MCM (Mushroom complete medium, glucose 20g/L). L, yeast extract 2g/L, peptone 2g/L, MgSO 4 7H 2 O 0.5g/L, K 2 HPO 4 1g/L, KH 2 PO 4 0.46g/L) Initial inoculation concentration in the medium at OD 600 It was inoculated to be 0.3, and cultured with shaking at 200 rpm at 25° C. and sampled every 24 hours to check the OD value, the amount of residual equivalent in the medium, and the amount of polysaccharide produced (FIGS. 3 and 4 ).
트리멜라 푸시포미스 TFC6 균주의 생장곡선을 위한 OD값은 600nm에서 흡광도로 측정하였으며, 배지 내 잔존 포도당량은 각 배양액을 12000rpm에서 15분간 원심분리하여 세포와 상등액을 분리하고, 분리된 상등액을 0.2μm 필터로 필터링한 후 이를 고성능 액체크로마토그래피 유량 0.6mL/min, 이동상 0.25mM H2SO4, 이온 교환 컬럼(300×78mm, Aminex HPX-87H, Bio-Rad), 시차굴절검출기(RID)를 이용한 조건에서 포도당량을 분석하였다. 배지 내 생성된 다당체는 에탄올 침전법에 의하여 측정되었다. 각 배양액을 12000rpm에서 15분간 원심분리하여 세포와 상등액을 분리하고, 세포와 분리된 상등액 12.5ml에 에탄올을 3배 (37.5ml) 처리하여 잘 섞어준 후 4℃에서 16시간 동안 반응시켜 다당체 침전을 유도하였다. 이를 12000rpm에서 15분간 원심분리하여 침전된 다당체를 회수하였으며, 동결건조하여 그 무게를 측정하였다. The OD value for the growth curve of the Trimela fusformis TFC6 strain was measured by absorbance at 600 nm, and the residual glucose in the medium was centrifuged at 12000 rpm for 15 minutes to separate cells and supernatant, and the separated supernatant was 0.2 After filtering with a μm filter, it was used with a high-performance liquid chromatography flow rate of 0.6 mL/min, a mobile phase 0.25 mM H 2 SO 4 , an ion exchange column (300×78mm, Aminex HPX-87H, Bio-Rad), and a differential refractive detector (RID). The amount of glucose was analyzed under the conditions used. The polysaccharide produced in the medium was measured by the ethanol precipitation method. Each culture was centrifuged at 12000 rpm for 15 minutes to separate the cells and the supernatant, treated with
그 결과 도 3 및 도 4에 나타낸 바와 같이, PDA와 MCM 배지를 통한 생장곡선 실험에서 사용한 두 배지 모두 배양 1-3일째에 대수증식기를 거쳐, 배양 4일째에 정체기에 도달함을 확인하였다. 그러나 MCM 배지에서의 생장이 OD600값으로 최대 35까지 나타나 PDA 배지에서 최대 14.7보다 2배 이상 높게 나타났으며, 생성된 다당체도 MCM 배지에서 약 2 g/l (4-6일째)로 PDA 배지에서 생성된 최대 다당체 약 0.9 g/l (6일째)보다 높게 나타났다. 이후 트리멜라 푸시포미스 TFC6 균주를 이용한 다당체 생성량 실험은 MCM 배지를 이용하여 수행하였다.As a result, as shown in Figs. 3 and 4, it was confirmed that both media used in the growth curve experiment using PDA and MCM media passed through the logarithmic growth phase on the first 1-3 days of culture and reached a plateau on the fourth day of culture. However, the growth in MCM medium showed up to 35 with OD 600 value, which was more than 2 times higher than the maximum 14.7 in PDA medium, and the resulting polysaccharide was also about 2 g/l (4-6 days) in MCM medium. The maximum polysaccharide produced in about 0.9 g / l (6th day) was higher than. Afterwards, Trimella Pushformis The polysaccharide production amount experiment using the TFC6 strain was performed using MCM medium.
실시예Example 3. 본 발명의 균사체 3. Mycelium of the present invention 트리멜라Trimella 푸시포미스Push Formis TFC6TFC6 균주 돌연변이체로부터 다당체 고생산 변이주의 분리 Isolation of high polysaccharide mutant strains from strain mutants
UV 돌연변이 생성을 위하여 흰목이버섯 TFC6 균주의 UV에 의한 사멸율을 확인하였다. MCM 고체 배지에 106세포/플레이트의 세포를 도말한 후 UV 램프로부터 약 30cm 거리를 두고 0, 1, 2, 3, 4, 5, 6, 10, 15분 동안 노출하였다. 이후 생장을 위해 25℃에서 약 7일간 배양하였으며, 배양 후 자라난 콜로니의 수를 세어 사멸율을 확인하였다. 도 5에서 나타나는 바와 같이 UV 노출시간이 5분 이상인 경우에는 자라나는 콜로니를 확인할 수 없었으며, 약 3분 30초간 UV에 노출되었을 때 생존율이 0.01% (사멸율 99.99%)임을 확인하였다. 이후 돌연변이를 일으키기 위하여 배지에 도말된 흰목이버섯 균주를 3분 30초 동안 동일한 조건에서 UV에 노출시켰다. 흰목이버섯 균사 106 세포를 각 플레이트에 도말 후 UV에 3분 30초간 노출하여 돌연변이를 유발 후 단일콜로니를 880개 확보하였다. 이후 돌연변이가 일어난 유전자의 안정화를 위하여 콜로니의 크기가 작은 것은 탈락시키면서 3차까지 계대배양을 수행하였다. 그 결과 3차 계대 배양 후 200개의 콜로니를 확보하였다. For the generation of UV mutations, the kill rate by UV of the TFC6 strain of white tree mushroom was confirmed. After plating 10 6 cells/plate of cells in MCM solid medium, they were exposed for 0, 1, 2, 3, 4, 5, 6, 10, 15 minutes at a distance of about 30 cm from the UV lamp. After that, the cells were cultured at 25° C. for about 7 days for growth, and the number of colonies grown after the culture was counted to check the death rate. As shown in FIG. 5, when the UV exposure time was 5 minutes or more, growing colonies could not be confirmed, and when exposed to UV for about 3 minutes and 30 seconds, it was confirmed that the survival rate was 0.01% (mortality rate 99.99%). Thereafter, in order to cause a mutation, the white-necked mushroom strain spread on the medium was exposed to UV under the same conditions for 3 minutes and 30 seconds. After smearing the white-
흰목이버섯 TFC6 균주의 UV 돌연변이 균주를 안정화를 위하여 3차까지 계대배양한 후, 이 중 크게 자라나는 콜로니 84개를 선별하여 3개의 세트로 나누어 MCM배지, 25℃, 200rpm에서 4일간 배양 후 OD값과 다당체 생성량을 측정하였다. 기본적으로 각 세트별로 다당체 생성량이 다르게 나타났기 때문에 각 세트마다 다당체 생성량이 가장 높은 균주를 각각 2개씩 선별하였고, 각 균주를 콜로니 번호에 따라 TFCUV-5, TFCUV-7, TFCUV-36, TFCUV-38, TFCUV-59, 그리고 TFCUV-82라 명명하였다.After subculturing the UV mutant strain of the TFC6 strain of white oyster mushroom to the third stage for stabilization, 84 large-growing colonies were selected, divided into three sets, and cultured in MCM medium, 25°C, 200 rpm for 4 days, and then OD value The amount of hyperpolysaccharide produced was measured. Basically, because the amount of polysaccharide production was different for each set, two strains with the highest polysaccharide production amount were selected for each set, and each strain was selected according to the colony number, TFCUV-5, TFCUV-7, TFCUV-36, TFCUV-38, and It was named TFCUV-59, and TFCUV-82.
흰목이버섯 TFC6 균주의 돌연변이 균주 중 가장 높은 다당체 생성량을 보인 TFCUV5 돌연변이 균주를 대상으로 동일한 배양조건에서 다당체 생성량을 배양시간에 따라 확인하였다. 그 결과 TFCUV5 돌연변이 균주는 배양 6일째에 다당체를 최대 3.6 g/l 생산하는 것으로 확인되었다(도 6).In the TFCUV5 mutant strain, which showed the highest polysaccharide production amount among the mutant strains of the TFC6 strain, the amount of polysaccharide production was confirmed under the same culture conditions according to the culture time. As a result, it was confirmed that the TFCUV5 mutant strain produced up to 3.6 g/l of polysaccharide on the 6th day of culture (FIG. 6).
실시예Example 4. 본 발명에서 분리한 다당체 고생산 균사체 4. Polysaccharide high-producing mycelium isolated in the present invention 트리멜라Trimella 푸시포미스Push Formis TFCUV5 돌연변이 균주의 발효공정 연구 Fermentation process study of TFCUV5 mutant strain
1) 탄소원, 질소원의 영향1) Influence of carbon and nitrogen sources
확보한 트리멜라 푸시포미스 TFCUV5 돌연변이 균주의 다당체 생산에 있어서 탄소원과 질소원을 달리하여 영향을 조사하였다. 다당체 생산 MCM 배지에서 20g/L의 탄소원(glucsoe, maltose, frutose, sucrose, lactose, mannitol, sorbitol, xylose)과 2g/L의 질소원(yeast extract, tryptone, soy peptone, ammonium sulfate, ammonium nitrate)을 각각 달리하여 25℃, 200rpm으로 250ml 플라스크에서 배양하였다. 그 결과, 표 4에 나타낸 바와 같이 글루코스, 수크로스가 탄소원으로 사용되었을 때 높은 수준의 다당체를 생산하였다. 한편 효모 추출물을 질소원으로 사용한 경우 최대 다당체 생산을 나타내었다. 유기 질소원과 비교하여 무기질소원은 상대적으로 더 높은 세포생산과 다당체 생산을 나타냈다.The effects of different carbon sources and nitrogen sources on the polysaccharide production of the obtained trimella fusformis TFCUV5 mutant strain were investigated. 20 g/L of carbon sources (glucsoe, maltose, frutose, sucrose, lactose, mannitol, sorbitol, xylose) and 2 g/L of nitrogen sources (yeast extract, tryptone, soy peptone, ammonium sulfate, ammonium nitrate) were each prepared in the polysaccharide-producing MCM medium. Alternatively, it was cultured in a 250 ml flask at 25° C. and 200 rpm. As a result, as shown in Table 4, when glucose and sucrose were used as carbon sources, a high level of polysaccharide was produced. Meanwhile, when yeast extract was used as a nitrogen source, the maximum polysaccharide production was shown. Compared with the organic nitrogen source, the inorganic nitrogen source showed relatively higher cell production and polysaccharide production.
(g/L)Cell dry weight
(g/L)
(g/L)Polysaccharide
(g/L)
2) 온도의 영향2) Influence of temperature
트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 이용하여 온도가 다당체 생산성에 미치는 영향에 대해 알아보았다. TFCUV5 균주를 250ml 플라스크(MCM 배지, 글루코스 20g/L, 효모 추출물 2g/L, 펩톤 2g/L, MgSO4·7H2O 0.5g/L, K2HPO4 1g/L, KH2PO4 0.46g/L)를 이용하여 온도(25, 28, 31, 34℃)를 달리하여 200rpm으로 회분식 배양하였으며, 동시에 배양 상등액의 다당체 생성량을 조사하였다. 그 결과, 도 7에 나타낸 바와 같이 배양온도 25℃에서 가장 높은 2.6g/L의 다당체(EPS: exopolysaccharide)를 생산하였다. The effect of temperature on the productivity of polysaccharides was investigated using the Trimela fusformis TFCUV5 mutant strain. TFCUV5 strain in a 250 ml flask (MCM medium, glucose 20 g/L, yeast extract 2 g/L, peptone 2 g/L, MgSO 4 7H 2 O 0.5 g/L, K 2 HPO 4 1 g/L, KH 2 PO 4 0.46 g /L) was used to batch culture at 200 rpm at different temperatures (25, 28, 31, 34°C), and at the same time, the amount of polysaccharide produced in the culture supernatant was investigated. As a result, as shown in FIG. 7, the highest 2.6 g/L polysaccharide (EPS) was produced at a culture temperature of 25°C.
3) 초기 pH의 영향3) Effect of initial pH
트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 이용하여 초기 pH가 다당체 생산성에 미치는 영향에 대해 알아보았다. TFCUV5 균주를 250ml 플라스크(MCM 배지, 글루코스 20g/L, 효모 추출물 2g/L, 펩톤 2g/L, MgSO4·7H2O 0.5g/L, K2HPO4 1g/L, KH2PO4 0.46g/L)를 이용하여 초기 pH(5.0, 6.0, 7.0, 8.0, 9.0)를 달리하여 25℃, 200rpm으로 회분식 배양하였으며, 동시에 배양 상등액의 다당체 생성량을 조사하였다. 그 결과, 도 8에 나타낸 바와 같이 초기 pH 7.0, 8.0, 9.0에서 별다른 큰 차이를 보이지 않았으며. 초기 pH 7.0에서 가장 높은 2.7g/L의 다당체를 생산하였다. The effect of initial pH on polysaccharide productivity was investigated using the Trimela fusformis TFCUV5 mutant strain. TFCUV5 strain in a 250 ml flask (MCM medium, glucose 20 g/L, yeast extract 2 g/L, peptone 2 g/L, MgSO 4 7H 2 O 0.5 g/L, K 2 HPO 4 1 g/L, KH 2 PO 4 0.46 g /L) was used to change the initial pH (5.0, 6.0, 7.0, 8.0, 9.0) to batch culture at 25°C and 200 rpm, and at the same time, the amount of polysaccharide produced in the culture supernatant was investigated. As a result, as shown in FIG. 8, there was no significant difference at the initial pH of 7.0, 8.0, and 9.0. The highest 2.7 g/L polysaccharide was produced at an initial pH of 7.0.
4) 교반속도의 영향4) Influence of stirring speed
트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 이용하여 교반속도가 다당체 생산성에 미치는 영향에 대해 알아보았다. TFCUV5 균주를 5L 발효조(MCM 배지, 글루코스 20g/L, 효모 추출물 2g/L, 펩톤 2g/L, MgSO4·7H2O 0.5g/L, K2HPO4 1g/L, KH2PO4 0.46g/L)를 이용하여 교반속도(100, 200, 300, 400, 500 rpm)를 달리하여 초기 pH 7.0, 25℃, 1.0vvm으로 회분식 배양하였으며, 동시에 배양 상등액의 다당체 생성량을 조사하였다. 그 결과, 도 9에 나타낸 바와 같이 교반속도가 100rpm일 때 다당체를 전혀 생산하지 않았고. 300rpm에서 가장 높은 3.2g/L의 다당체를 생산하였다. The effect of agitation speed on polysaccharide productivity was investigated using the Trimela fusformis TFCUV5 mutant strain. TFCUV5 strain in a 5L fermenter (MCM medium, glucose 20g/L, yeast extract 2g/L, peptone 2g/L, MgSO 4 7H 2 O 0.5g/L, K 2 HPO 4 1g/L, KH 2 PO 4 0.46 g /L) was used to vary the stirring speed (100, 200, 300, 400, 500 rpm) to perform batch culture at an initial pH of 7.0, 25° C., 1.0 vvm, and at the same time, the amount of polysaccharide produced in the culture supernatant was investigated. As a result, polysaccharides were not produced at all when the stirring speed was 100 rpm as shown in FIG. 9. The highest 3.2 g/L polysaccharide was produced at 300 rpm.
5) 공기주입량의 영향5) Influence of air injection volume
트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 이용하여 공기주입량이 다당체 생산성에 미치는 영향에 대해 알아보았다. TFCUV5 균주를 5L 발효조(MCM 배지, 글루코스 20g/L, 효모 추출물 2g/L, 펩톤 2g/L, MgSO4·7H2O 0.5g/L, K2HPO4 1g/L, KH2PO4 0.46g/L)를 이용하여 공기주입량(0.5, 1.0, 2.0vvm)를 달리하여 초기 pH 7.0, 25℃, 300rpm으로 회분식 배양하였으며, 동시에 배양 상등액의 다당체 생성량을 조사하였다. 그 결과, 도 10에 나타낸 바와 같이 공기주입량이 0.5vvm일 때 다당체를 전혀 생산하지 않았고. 2.0vvm에서 가장 높은 4.3g/L의 다당체를 생산하였다. The effect of air injection on the productivity of polysaccharides was investigated using the Trimela fusformis TFCUV5 mutant strain. TFCUV5 strain in a 5L fermenter (MCM medium, glucose 20g/L, yeast extract 2g/L, peptone 2g/L, MgSO 4 7H 2 O 0.5g/L, K 2 HPO 4 1g/L, KH 2 PO 4 0.46 g /L) was used to vary the amount of air injection (0.5, 1.0, 2.0vvm) to perform batch culture at an initial pH of 7.0, 25°C, and 300 rpm, and at the same time, the amount of polysaccharide produced in the culture supernatant was investigated. As a result, as shown in FIG. 10, when the air injection amount was 0.5vvm, no polysaccharide was produced. The highest 4.3 g/L polysaccharide was produced at 2.0 vvm.
6) 유가식 배양6) fed-batch culture
트리멜라 푸시포미스 TFCUV5 돌연변이 균주를 이용하여 유가식 배양을 수행하였다. 5L 발효조(MCM 배지, 글루코스 20g/L, 효모 추출물 2g/L, 펩톤 2g/L, MgSO4·7H2O 0.5g/L, K2HPO4 1g/L, KH2PO4 0.46g/L)를 이용하여 초기 pH 7.0, 25℃, 300rpm, 2.0vvm으로 배양하였으며, 동시에 배양 상등액의 글루코스 잔존량과 다당체 생성량을 조사하였다. 그 결과, 도 11에 나타낸 바와 같이 배양 108시간째에 약 39.6g/L의 글루코즈를 사용하여 8.4g/L의 다당체를 생산하였으며(도 11), 다당체 생산성은 1.9g/L·day이었다. 사용된 포도당 영양원 대비 다당체 생산수율은 0.19g/g 글루코스로 확인되었다. 문헌상으로 보고된 다른 흰목이버섯 유래 균사체들의 다당체 생산 결과들과 비교해 볼 때, TFCUV5 변이균주는 우수한 다당체 생산량 나타냈다(Jant et al., 2008, Journal of Mushroom Science and Production March;6(1);27-31). Fed-batch cultivation was performed using trimella fusformis TFCUV5 mutant strain. 5L fermentation tank (MCM medium, glucose 20g/L, yeast extract 2g/L, peptone 2g/L, MgSO 4 7H 2 O 0.5g/L, K 2 HPO 4 1g/L, KH 2 PO 4 0.46g/L) By using the initial pH 7.0, 25 ℃, 300rpm, was cultured at 2.0vvm, and at the same time, the amount of glucose remaining in the culture supernatant and the amount of polysaccharide produced were examined. As a result, as shown in FIG. 11, 8.4 g/L of polysaccharide was produced using about 39.6 g/L of glucose at 108 hours of culture (FIG. 11), and the polysaccharide productivity was 1.9 g/L·day. The polysaccharide production yield compared to the glucose nutrient used was found to be 0.19g/g glucose. Compared with the results of polysaccharide production of other white mushroom-derived mycelium reported in the literature, the TFCUV5 mutant showed excellent polysaccharide production (Jant et al., 2008, Journal of Mushroom Science and Production March;6(1);27) -31).
실시예Example 5. 5. 흰목이버섯White-throated mushroom 균사체 mycelium 트리멜라Trimella 푸시포미스Push Formis TFCUV5TFCUV5 돌연변이 균주 유래 다당체 당 조성 분석 Analysis of the composition of polysaccharides derived from mutant strains
트리멜라 푸시포미스 TFCUV5 돌연변이 균주 배양을 통해 얻어진 다당체의 당 조성을 분석하였다. 분석 방법은 다음과 같다. 마이크로원심분리 튜브에 시료 100 ㎍과 2M TFA 400 ㎕를 각각 넣고, 100℃ 히트 블럭에 넣고 4 시간 동안 가수분해한 후, 실온으로 식히고 진공원심농축기에서 건조하였다. 그 후, 시료를 3차수 2 ㎖에 녹이고 0.2 ㎛ 필터로 여과한 후 글루쿠론산 가수분해를 수행하고, 마이크로원심분리 튜브에 시료 100 ㎍ 및 2M TFA 400 ㎕를 각각 넣고, 100℃ 히트 블럭에 넣고 4 시간 동안 가수분해한 후, 실온으로 식히고 진공원심농축기에서 건조하고, 3차수 1 ㎖에 녹이고 0.2 ㎛ 필터로 여과하였다.The sugar composition of the polysaccharide obtained through cultivation of the Trimela fusformis TFCUV5 mutant strain was analyzed. The analysis method is as follows. 100 µg of a sample and 400 µl of 2M TFA were placed in a microcentrifuge tube, respectively, placed in a 100°C heat block, hydrolyzed for 4 hours, cooled to room temperature, and dried in a vacuum centrifuge. Thereafter, the sample was dissolved in 2 ml of third water, filtered through a 0.2 μm filter, and then hydrolyzed with glucuronic acid, and 100 μg of the sample and 400 μl of 2M TFA were respectively added to a microcentrifuge tube, and placed in a heat block at 100°C. After hydrolysis for 4 hours, it was cooled to room temperature, dried in a vacuum centrifugal concentrator, dissolved in 1 ml of third order water, and filtered through a 0.2 μm filter.
소듐 아세테이트100 mM NaOH/150 mM
Sodium acetate
AminTrap (3x30 ㎜, Dionex
060146)CarboPac PA20 column (3 x 150 mm, Dionex, 060142) and
AminTrap (3x30 ㎜, Dionex
060146)
㎜, Dionex, 035391) 및 가이드컬럼 (4×50 ㎜, Dionex,
043096)CarboPac PA1 column (4×250
Mm, Dionex, 035391) and guide column (4×50 mm, Dionex,
043096)
HPAEC로 측정된 값을 무게로 환산하고, 분석에 사용한 단백질 양(0.5 또는 1 ㎍)으로 나누어 값을 구하였다. 이때, 변환에 사용된 각 단당의 분자량은 시료 다당체가 중합체로 구성된 것으로 가정하고, 각 glycosidic bonding에서 빠져나간 물 분자량 18D을 뺀 값을 사용하였다. 그 결과, 하기 표 6에 나타낸 바와 같이, 만노스, 자일로스, 글루쿠론산, 푸코스 및 글루코스가 각각 40.3, 22.0, 19.3, 17.1, 1.3%의 구성을 나타냈다.The value measured by HPAEC was converted into weight, and the value was calculated by dividing it by the amount of protein (0.5 or 1 μg) used for analysis. At this time, the molecular weight of each monosaccharide used for conversion was assumed to be composed of a polymer, and a value obtained by subtracting 18D of the molecular weight of water that escaped from each glycosidic bonding was used. As a result, as shown in Table 6 below, mannose, xylose, glucuronic acid, fucose, and glucose exhibited a composition of 40.3, 22.0, 19.3, 17.1, and 1.3%, respectively.
트리멜라 푸시포미스 TFCUV5 돌연변이 균주 배양을 통해 얻어진 다당체의 일반미생물 함량을 식품공전(2015) 미생물시험법을 따라 측정한 결과, 음성으로 나타났다.As a result of measuring the general microbial content of the polysaccharide obtained through cultivation of the Trimela fusformis TFCUV5 mutant strain according to the Food Code (2015) microbial test method, it was found to be negative.
실시예Example 6. 6. 흰목이버섯White-throated mushroom 균사체 mycelium 트리멜라Trimella 푸시포미스Push Formis TFCUV5TFCUV5 돌연변이 균주 유래 다당체 아미노산 분석 Analysis of polysaccharide amino acids derived from mutant strains
트리멜라 푸시포미스 TFCUV5 돌연변이 균주 배양을 통해 얻어진 다당체의 아미노산을 분석하였으며, 분석 방법은 다음과 같다.The amino acids of the polysaccharide obtained through the culture of the Trimela fusformis TFCUV5 mutant strain were analyzed, and the analysis method is as follows.
[일반 아미노산 분석을 위한 시료 전처리][Sample preparation for general amino acid analysis]
1. 시료 튜브에 시료 100 ㎍을 넣고 건조하였다.1. Put 100 ㎍ of a sample in a sample tube and dried.
2. 반응 바이알에 시료 튜브와 6 M HCl 200 ㎕, 페놀 2 ㎕ 넣었다.2. A sample tube, 200 µl of 6 M HCl, and 2 µl of phenol were added to the reaction vial.
3. 110℃에서 24 시간 가수분해하였다.3. Hydrolyzed at 110° C. for 24 hours.
4. 반응이 끝난 시료에 노르류신(norleucine) 25 n㏖을 넣고 재건조하였다.4. After the reaction was completed, 25 nmol of norleucine was added and dried again.
5. Pico·Tag™ Manual에 따라 PITC로 표지하고 건조하였다.5. According to Pico·Tag™ Manual, it was labeled with PITC and dried.
6. 시료를 HPLC 용매 A 400 ㎕에 녹였다.6. The sample was dissolved in 400 µl of HPLC solvent A.
[시스테인 분석을 위한 시료 전처리][Sample preparation for cysteine analysis]
1. 시료 튜브에 시료 100 ㎍을 넣고 건조하였다.1. Put 100 ㎍ of a sample in a sample tube and dried.
2. 시료 튜브에 포름산:과산화수소=10:1 용액 10 ㎕를 넣고 30분간 실온반응 후 건조하였다.2. 10 µl of a solution of formic acid: hydrogen peroxide = 10:1 was added to the sample tube and reacted at room temperature for 30 minutes, followed by drying.
3. 반응 바이알에 시료 튜브와 6 M HCl 200 ㎕, 페놀 2 ㎕ 넣었다.3. A sample tube, 200 µl of 6 M HCl, and 2 µl of phenol were added to the reaction vial.
4. 110℃에서 24 시간 가수분해하였다.4. Hydrolyzed at 110° C. for 24 hours.
5. 반응이 끝난 시료에 노르류신(norleucine) 25 n㏖을 넣고 재건조하였다.5. After the reaction was completed, 25 nmol of norleucine was added and dried again.
6. Pico·Tag™ Manual에 따라 PITC로 표지하고 건조하였다.6. According to Pico·Tag™ Manual, it was labeled with PITC and dried.
7. 시료를 HPLC 용매 A 400 ㎕에 녹였다.7. The sample was dissolved in 400 µl of HPLC solvent A.
[트립토판 분석을 위한 시료 전처리][Sample preparation for tryptophan analysis]
1. 시료 튜브에 시료 100 ㎍을 넣고 건조하였다.1. Put 100 ㎍ of a sample in a sample tube and dried.
2. 4 M 메탄술폰산 20 ㎕를 시료 튜브에, 3차수 100 ㎕를 반응 바이알에 넣었다.2. Put 20 µl of 4M methanesulfonic acid into the sample tube and 100 µl of the third order into the reaction vial.
3. 110℃에서 24 시간 가수분해하였다.3. Hydrolyzed at 110° C. for 24 hours.
4. 반응이 끝난 시료에 노르류신(norleucine) 25 n㏖을 넣고 재건조하였다.4. After the reaction was completed, 25 nmol of norleucine was added and dried again.
5. Pico·Tag™ Manual에 따라 PITC로 표지하고 건조하였다.5. According to Pico·Tag™ Manual, it was labeled with PITC and dried.
6. 시료를 HPLC 용매 A 400 ㎕에 녹였다.6. The sample was dissolved in 400 µl of HPLC solvent A.
trihydrate/0.1% TEA, pH 5.9
in 6% acetonitrile (%)A: 140 mM sodium acetate
trihydrate/0.1% TEA, pH 5.9
in 6% acetonitrile (%)
(%)B: 60% acetonitrile in water
(%)
분석된 아미노산 결과는 하기 표 9 및 도 12에 나타냈다. 히스티딘 및 트립토판은 검출되지 않았다. BCA 분석으로 본 약 1.5 ㎍ BSA eq/100 ㎍ TFC 값과 아미노산 합계인 1.21 g/100 g 값이 거의 일치한 것으로 보아 시료의 단백 성분이 1.2% 수준임을 알 수 있었다.The analyzed amino acid results are shown in Table 9 and FIG. 12 below. Histidine and tryptophan were not detected. BCA analysis showed that the 1.5 µg BSA eq/100 µg TFC value and the amino acid sum of 1.21 g/100 g were almost identical, indicating that the protein content of the sample was at the level of 1.2%.
acidAmino
acid
(pmol)TFC
(pmol)
(pmol)IS corrected
(pmol)
실시예Example 7. 7. 트리멜라Trimella 푸시포미스Push Formis TFCUV5TFCUV5 돌연변이 균주 유래 다당체 구조 분석 Analysis of polysaccharide structure derived from mutant strain
트리멜라 푸시포미스 TFCUV5 돌연변이 균주 배양액으로부터 분리된 다당체의 작용기를 확인하기 위하여 KBr 디스크 방법을 이용하여 박막을 만든 후 FT-IR (JASCO FT-IR 4100) 분석을 수행하였다. FT-IR 분석 수행 결과, 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 배양액으로부터 분리된 다당체는 히드록시기 및 카르복시기, O-아세틸기 그리고 글루쿠론산을 포함하고 있음을 확인하였다(도 13). 3325.04 cm-1 주변에 강하고 넓은 피크는 히드록시기를 나타내며, 1720.99 cm-1에 나타나는 피크 및 1411.92~1374.39 cm-1 근처에서 대칭으로 나타나는 두 개의 피크는 카르복시기를 나타내었다. 또한 1249.38 cm-1과 1022.28 cm-1은 각각 O-아세틸기 및 글루쿠론산을 나타내었다(도 13). 이러한 결과는 이전에 보고되었던 트리멜라 속 유래 다당체에서 나타나는 IR 스펙트럼과 유사하였다.In order to confirm the functional groups of polysaccharides isolated from the culture of the Trimela fusformis TFCUV5 mutant strain, a thin film was prepared using the KBr disk method, and then FT-IR (JASCO FT-IR 4100) analysis was performed. As a result of performing FT-IR analysis, it was confirmed that the polysaccharide isolated from the culture medium of the Trimela fusformis TFCUV5 mutant strain contained a hydroxy group, a carboxyl group, an O-acetyl group, and a glucuronic acid (FIG. 13). Strong and broad peaks around 3325.04 cm -1 represents a hydroxy group, two peaks appear symmetrically in the peak and near 1411.92 ~ 1374.39 cm -1 appear to 1720.99 cm -1 exhibited a carboxy group. In addition, 1249.38 cm -1 and 1022.28 cm -1 each represented an O-acetyl group and glucuronic acid (FIG. 13). These results were similar to the previously reported IR spectrum of polysaccharides derived from the genus Trimela.
실시예Example 8. 8. 트리멜라Trimella 푸시포미스Push Formis TFCUV5TFCUV5 돌연변이 균주 유래 다당체 분자량 분석 Molecular weight analysis of polysaccharides derived from mutant strains
트리멜라 푸시포미스 TFCUV5 돌연변이 균주 배양액으로부터 분리된 다당체의 평균 분자량은 고성능 액체크로마토그래피-MALS(Multi-angle light scattering) 시스템(Wyatt Technology, Santa Babara, CA)에서 SEC 컬럼(TSK-gel-GMPWXL, 30 cm × 7.8 mm, 13 μm, Tosoh)을 이용하여 분석하였다. 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 배양액으로부터 분리된 다당체를 인산완충 생리식염수(pH 7.3~7.5)에 용해하여 3 mg/mL의 농도로 샘플을 준비하여 분석하였다. 준비된 샘플은 고성능 액체크로마토그래피 유량 0.5 mL/min, 인젝션 볼륨 100㎕, 이동상 인산완충생리식염수(pH 7.3~7.5), 검출기 DAWN HELEOS II, Optilab rEX를 이용한 조건으로 분석하였다. 분자량 계산시 dn/dc값(specific refractive index increment)은 문헌을 참고하여 0.15 mL/g으로 결정하였다. 트리멜라 푸시포미스 TFCUV5 돌연변이 균주 배양액으로부터 분리된 다당체 평균 분자량의 계산은 ASTRA 6 software(Wyatt Technology)를 이용하여 분석하였다. 상기 방법으로 분석한 다당체의 평균 분자량은 1.79 × 106(±0.721%)으로 확인하였다(도 14).The average molecular weight of the polysaccharide isolated from the culture of the Trimela fusformis TFCUV5 mutant strain was determined by a high-performance liquid chromatography-MALS (Multi-angle light scattering) system (Wyatt Technology, Santa Babara, CA) in a SEC column (TSK-gel-GMPWXL, CA). 30 cm × 7.8 mm, 13 μm, Tosoh). The polysaccharide isolated from the culture of the Trimela fusformis TFCUV5 mutant strain was dissolved in phosphate buffered saline (pH 7.3 to 7.5) to prepare and analyze a sample at a concentration of 3 mg/mL. The prepared samples were analyzed under the conditions of high performance liquid chromatography flow rate 0.5 mL/min,
<110> Korea Research Institute of Bioscience and Biotechnology Microbiome Co., Ltd. <120> Mycelium Tremella fucifomis TFCUV5 mutant strain having high growth rate and polysaccharide productivity and uses thereof <130> PN16449 <160> 6 <170> KopatentIn 2.0 <210> 1 <211> 295 <212> DNA <213> Tremella fucifomis <400> 1 ggccgtgagg ccttccaaca cctgtgcaca tcggaccgcg cccccgggcc gggctgcctt 60 cacacaaaca tatgtcaaga acgtaatgca tcataacatg aaacaacttt caacaacgga 120 tctcttggct ctcgcatcga tgaagaacgc agcgaattgc gaaaagtaat gtgaattgca 180 gaattcagtg aatcatcgaa tctttgaacg caccttgcgc cttttggtat tccgaaaggc 240 atgcctgttt gagtgtcatg tagactcaac cccccgggtt tctgacccgg cggtg 295 <210> 2 <211> 570 <212> DNA <213> Tremella fucifomis <400> 2 ccctagtacg gcgagcgaac cgggaagagc tcaaatttga aatctggcgt cctccgggcg 60 tccgagttgt aatctacaga ggcgttttcc gcgccggtcc gcgtccaagt cccttggaac 120 agggtatcaa agagggtgac aatcccgtac ttgacacgac cgccggtgct ttgtgatacg 180 tcttctaaga gtcgagttgt ttgggaatgc agctcaaaac gggtggtaaa ttccatctaa 240 ggctaaatat tggcgagaga ccgatagcga acaagtaccg tgagggaaag atgaaaagca 300 ctttggaaag agagttaaac agcacgtgaa attgttgaaa gggaaacgat tgaagtcagt 360 cgtgtccggg gggttcagcc ggttctgccg gtgcattcct ctcggacggg tcaacatcgg 420 ttttgcccgg cggaaaaggg cgtgaggaat gtggcacctc cgggtgtgtt atagcctcgc 480 gtcgcatacg tcgggcggga ccgaggaacg cagctcgcct tcacggccgg ggttcgccca 540 cgtacgagct taggatgttg acataatggc 570 <210> 3 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 tccgtaggtg aacctgcgg 19 <210> 4 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 tcctccgctt attgatatgc 20 <210> 5 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 gcatatcaat aagcggagga aaag 24 <210> 6 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 ggtccgtgtt tcaagacgg 19 <110> Korea Research Institute of Bioscience and Biotechnology Microbiome Co., Ltd. <120> Mycelium Tremella fucifomis TFCUV5 mutant strain having high growth rate and polysaccharide productivity and uses thereof <130> PN16449 <160> 6 <170> KopatentIn 2.0 <210> 1 <211> 295 <212> DNA <213> Tremella fucifomis <400> 1 ggccgtgagg ccttccaaca cctgtgcaca tcggaccgcg cccccgggcc gggctgcctt 60 cacacaaaca tatgtcaaga acgtaatgca tcataacatg aaacaacttt caacaacgga 120 tctcttggct ctcgcatcga tgaagaacgc agcgaattgc gaaaagtaat gtgaattgca 180 gaattcagtg aatcatcgaa tctttgaacg caccttgcgc cttttggtat tccgaaaggc 240 atgcctgttt gagtgtcatg tagactcaac cccccgggtt tctgacccgg cggtg 295 <210> 2 <211> 570 <212> DNA <213> Tremella fucifomis <400> 2 ccctagtacg gcgagcgaac cgggaagagc tcaaatttga aatctggcgt cctccgggcg 60 tccgagttgt aatctacaga ggcgttttcc gcgccggtcc gcgtccaagt cccttggaac 120 agggtatcaa agagggtgac aatcccgtac ttgacacgac cgccggtgct ttgtgatacg 180 tcttctaaga gtcgagttgt ttgggaatgc agctcaaaac gggtggtaaa ttccatctaa 240 ggctaaatat tggcgagaga ccgatagcga acaagtaccg tgagggaaag atgaaaagca 300 ctttggaaag agagttaaac agcacgtgaa attgttgaaa gggaaacgat tgaagtcagt 360 cgtgtccggg gggttcagcc ggttctgccg gtgcattcct ctcggacggg tcaacatcgg 420 ttttgcccgg cggaaaaggg cgtgaggaat gtggcacctc cgggtgtgtt atagcctcgc 480 gtcgcatacg tcgggcggga ccgaggaacg cagctcgcct tcacggccgg ggttcgccca 540 cgtacgagct taggatgttg acataatggc 570 <210> 3 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 tccgtaggtg aacctgcgg 19 <210> 4 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 tcctccgctt attgatatgc 20 <210> 5 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 gcatatcaat aagcggagga aaag 24 <210> 6 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 ggtccgtgtt tcaagacgg 19
Claims (8)
상기 다당체는 만노스, 자일로스, 글루쿠론산, 푸코스 및 글루코스로 이루어진 것을 특징으로 하는 균주.As a mycelium trimella fucifomis TFCUV5 mutant strain (accession number: KCTC18504P) having excellent growth rate and polysaccharide productivity,
The polysaccharide strain, characterized in that consisting of mannose, xylose, glucuronic acid, fucose and glucose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180068699A KR102199666B1 (en) | 2018-06-15 | 2018-06-15 | Mycelium Tremella fucifomis TFCUV5 mutant strain having high growth rate and polysaccharide productivity and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180068699A KR102199666B1 (en) | 2018-06-15 | 2018-06-15 | Mycelium Tremella fucifomis TFCUV5 mutant strain having high growth rate and polysaccharide productivity and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190141905A KR20190141905A (en) | 2019-12-26 |
KR102199666B1 true KR102199666B1 (en) | 2021-01-07 |
Family
ID=69103688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180068699A Active KR102199666B1 (en) | 2018-06-15 | 2018-06-15 | Mycelium Tremella fucifomis TFCUV5 mutant strain having high growth rate and polysaccharide productivity and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102199666B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116254306B (en) * | 2021-12-01 | 2025-01-28 | 北京化工大学 | A method for producing Tremella polysaccharide by fermentation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100823681B1 (en) * | 2006-02-23 | 2008-04-29 | 중앙대학교 산학협력단 | Composition of culture medium for Tremella fuciformis and culturing method of the same |
KR20080079962A (en) * | 2007-02-28 | 2008-09-02 | 윤종원 | Antidiabetic Activated Extracellular Polysaccharides derived from Bacillus mycelium Mycelia |
KR20110052095A (en) * | 2009-11-12 | 2011-05-18 | (주)파파야 피부과학연구소 | Cosmetic composition for moisturizing skin containing mushroom extract |
KR20150058813A (en) * | 2013-11-21 | 2015-05-29 | 주식회사 엘씨에스바이오텍 | Mucous substance from Tremella fuciformis, method for producing the same and composition comprising the same |
-
2018
- 2018-06-15 KR KR1020180068699A patent/KR102199666B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20190141905A (en) | 2019-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60131752T2 (en) | BACILLUS SUBTILIS VAR. CHUNGKOOKJANG FOR THE PREPARATION OF POLY-GAMMA GLUTAMIC ACID WITH HIGH MOLECULAR WEIGHT | |
Cho et al. | Production of exopolysaccharides by submerged mycelial culture of a mushroom Tremella fuciformis | |
US20250122249A1 (en) | Purification of phycobiliproteins | |
Liesack et al. | Chemical composition of the peptidoglycan-free cell envelopes of budding bacteria of the Pirella/Planctomyces group | |
Wu et al. | Optimization of fermentation conditions for the production of pullulan by a new strain of Aureobasidium pullulans isolated from sea mud and its characterization | |
JP2021019577A (en) | Fermented birch sap and production method thereof | |
WO2018225557A1 (en) | Extracellular polysaccharide of lactic acid bacteria and use thereof | |
CN108913641B (en) | A kind of recombinant Escherichia coli and its application | |
CN109988799A (en) | Application of a kind of glycerol-2-α-glucosylase in the preparation of 2-α-glycerol glucoside | |
WO2009154320A1 (en) | Aureobasidium pullulans np-1221 kctc 11265bp and a producing method for exo-type beta-glucan using the same | |
CN109609525A (en) | Grifola frondosa glucan synthase, its encoding gene and application | |
KR102199666B1 (en) | Mycelium Tremella fucifomis TFCUV5 mutant strain having high growth rate and polysaccharide productivity and uses thereof | |
KR100438009B1 (en) | A cosmetic composition containing an extract of Grifola frondosa | |
CN108948151B (en) | Peptide and its preparation method and application | |
CN112708571B (en) | Recombinant yeast for fermenting and producing controllable molecular weight chondroitin sulfate and its application | |
KR102499330B1 (en) | Cosmetic composition containing culture with complex strains separated from kombucha for skin barrier reinforcement | |
CN114854722B (en) | Off-cut beta-1, 3-glucanase of candida mongolica and mutant and application thereof | |
KR101253471B1 (en) | Method for preparing beta-glycosidase protein and converting ginsenoside | |
KR102405854B1 (en) | cosmetic composition for skin moisturizing and wrinkle improvement using Lactobacillus kunkeei Hankook-001strain | |
US6197571B1 (en) | Protein polysaccharide 0041 | |
CN107794263B (en) | A gene for improving melanin yield and its application | |
WO1997023605A1 (en) | Thermostable proteolytic enzyme from thermoactinomyces thalpophilus thm1 | |
Nieth et al. | The protein patterns of intracytoplasmic membranes and reaction center particles isolated from Rhodopseudomonas capsulata | |
KR101090657B1 (en) | Strains of the genus Bacillus having activity in antler fermentation and methods for producing antler fermentation extracts using the same | |
KR101069686B1 (en) | A NOVEL Phellinus sp. STRAIN AND POLYSACCHARIDE THEREFROM HAVING ANTITUMOR AND IMMUNE ACTIVITY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20180615 |
|
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20190613 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20180615 Comment text: Patent Application |
|
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200611 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20201224 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20201231 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20201231 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20231115 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20241021 Start annual number: 5 End annual number: 5 |